Tenax Therapeutics (TENX) Other Operating Expenses (2011 - 2022)
Tenax Therapeutics (TENX) reported Other Operating Expenses of -$2355.0 for Q2 2022, up 99.05% on a YoY basis from -$1183.1 in Q2 2021, and down 859.68% sequentially from $310.0 in Q1 2022.
Tenax Therapeutics (TENX) Other Operating Expenses (2011 - 2022) Analysis & Trends
Tenax Therapeutics (TENX) has 8 years of Other Operating Expenses data on file, last reported at -$2355.0 in Q2 2022.
- For the quarter ending Q2 2022, Other Operating Expenses rose 99.05% year-over-year to -$2355.0; the trailing twelve-month figure through Mar 2023 stood at -$2355.0 (up 99.07% YoY), and the FY2021 full-year result was -$254832.0, down 1302.8% from the prior year.
- Other Operating Expenses eased to -$2355.0 in Q2 2022, from $310.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $310.0 in Q1 2022 to a low of -$247820.0 in Q2 2021.
- A 3-year average of -$33287.9 and a median of -$2998.5 in 2021 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses jumped 31.26% in 2021 and surged 114.52% in 2022, its largest moves.
- Tracing TENX's Other Operating Expenses over 3 years: stood at -$4128.0 in 2020, then surged by 70.08% to -$1235.0 in 2021, then tumbled by 90.69% to -$2355.0 in 2022.
- Business Quant data shows TENX's Other Operating Expenses at -$2355.0 in Q2 2022, $310.0 in Q1 2022, and -$1235.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -2,355.00 |
| Mar 31, 2022 | 310.00 |
| Dec 31, 2021 | -1,235.00 |
| Sep 30, 2021 | -3,642.00 |
| Jun 30, 2021 | -247,820.00 |
| Mar 31, 2021 | -2,135.00 |
| Dec 31, 2020 | -4,128.00 |
| Sep 30, 2020 | -5,298.00 |
| Dec 31, 2016 | 33.27 Mn |
| Jun 30, 2015 | 1.03 Mn |
| Apr 30, 2013 | 27,279.00 |
| Apr 30, 2012 | 29,534.00 |
| Apr 30, 2011 | 302,044.00 |